Press Releases

Baptist Health South Florida and The START Center for Cancer Research Announce Strategic Partnership to Expand Patient Access to Early-Phase Cancer Trials

New START site to be established in collaboration with Baptist Health Herbert Wertheim Cancer Institute will bring novel oncology therapies closer to patients across South Florida.

Syncell Launches High-Precision Proteomics Discovery Service Powered by Microscoop® Mint Platform

Syncell announced the commercial launch of Syncell Discovery Services, a new sample-to-discovery offering that gives biopharma, translational, and academic researchers direct access to insights generated by the company’s unbiased nanoscopic Microscoop Mint platform.

‘Biopharma innovators must widen CDMO networks to accelerate development’ says Shilpa Biologicals CEO ahead of BIO San Diego

Ahead of BIO San Diego, Shilpa Biologicals urges biotech innovators to engage CDMO partners earlier and look beyond large-scale providers. Over-relying on a narrow network of large CDMOs increases the risk of scope creep, severe clinical trial delays, and budget overruns of up to 40%. Conversely, incorporating smaller CDMOs can lower costs and accelerate timelines from discovery to clinic by several months.

Quotient Sciences Advances AI-Designed Drug Product into Clinical Development

Ardena appoints Ariane de Ganck as Chief Scientific Officer

DNAnexus Scales AI-Driven Capabilities : 17-Year Multiomics Pioneer Powers Next Era of Precision Health

DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world's most scientifically complex data becomes the world's most powerful AI fuel.

Pfizer and Innovent Biologics Enter $10.5 Billion Oncology Drug Development Partnership for 12 Cancer Programs

Pfizer and Innovent Biologics have formed a major oncology partnership worth up to $10.5 billion to develop 12 cancer treatment programs, including antibody-drug conjugates (ADCs) and multispecific antibodies. Pfizer will pay $650 million upfront, with additional milestone-based payments tied to development and commercialization progress. The collaboration combines Innovent’s early-stage research capabilities with Pfizer’s global development and commercialization expertise, aiming to accelerate the delivery of innovative cancer therapies worldwide.

Neuland reports record quarterly revenue of $83M* driven by commercial NCE projects

Quarterly revenue growth up 135% year-on-year, with total revenues passing ₹2000 crore for the first time

Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally

CellCarta and Leica Biosystems have announced a strategic partnership to bring a proven companion diagnostic (CDx) joint development model from China to biopharma sponsors globally.

Kivo Expands Life Sciences Leadership Team with Appointment of Former Veeva Executive Chris Xistris

Kivo, the unified document and process management system for life sciences teams, announced today that Chris Xistris has joined the company as Vice President of Services.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

Life Sciences Industry Veteran Appointed to Lead Global Commercial Organization

VoxCell BioInnovation and adMare BioInnovations Partner to Advance Novel Antibody Therapies in a Human-Relevant Vascularized Tissue Platform

Kivo Launches Headless GxP to Power Compliant Agentic AI in Drug Development

New open architecture connects AI agents, regulated workflows, and human-authenticated action to Kivo’s GxP-compliant platform.

Yourgene Health Launches Insight DPYD Assay

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

Atrandi Biosciences Expands Leadership Team to Accelerate Global Adoption of Capsule-Based Single-Cell Technology

Atrandi announced the appointments of Sam Ropp as Chief Commercial Officer and Susan Tousi as Chairman of the Board. These additions strengthen Atrandi’s leadership team as the company accelerates global adoption of its single-cell multiomic SPC technology.

NGI Becomes First Certified Core Lab and Service Provider for Epigenica’s EpiFinder™ Platforms

Epigenica AB has announced an agreement with the National Genomics Infrastructure, one of the largest technical platforms at SciLifeLab.

Medix Biochemica Announces $5 Million Investment to Expand Recombinant Antigen Capabilities

Medix Biochemica has announced a Board-approved $5 million investment to expand its recombinant antigen and cell culture technology capabilities across its Espoo, Finland and St. Louis, Missouri facilities.

Signant Health Acquires Ametris to Create an End-to-End eCOA and Digital Outcome Measures Platform

Signant Health, the evidence generation company, today announced its acquisition of Ametris (formerly ActiGraph), a global digital health solutions provider.

eClinical Solutions and Hobson & Company Quantify Financial and Operational Value of a Clinical Data Intelligence Platform for Clinical Trials

Bringing price transparency to clinical trial technology investment and return, company unveils ROI calculator for pharmaceutical companies and CROs

NunaBio secures £6.5 million to scale next-generation DNA platform and advance infrastructure for synthetic biology